Biotechnology
Filter News
Found 7,238 articles
-
Blade Therapeutics Announces Selection Of A Clinical Development Candidate And Funding Of The Second Tranche For Its Series B Financing
10/18/2017
Blade Therapeutics announced that it has nominated a clinical development candidate for its lead program focused on small molecule inhibitors that selectively target certain intracellular cysteine proteases.
-
Biotime, Inc. Announces Closing Of Public Offering And Underwriters’ Full Exercise Of Over-Allotment Option
10/18/2017
BioTime, Inc. announced the closing of its previously announced public offering of 9,615,385 shares of common stock, including 1,442,308 shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares.
-
Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017
10/18/2017
The conference call will be available via phone and webcast.
-
Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast
10/18/2017
Management will host a conference call on that date at 10:00 a.m. EDT to discuss these results and provide an update on the company.
-
pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
10/18/2017
Management will host a conference call to review the results at 8:30 a.m. ET on the same day.
-
Albumedix Establishes Scientific Advisory Board
10/18/2017
Albumedix has announced the formation of a Scientific Advisory Board (SAB) to provide governance, oversight and advice to Albumedix's R&D organization as it builds and develops its pipeline of proprietary and differentiated drugs.
-
AELIX Therapeutics Appoints Dr. Thomas Hecht As Chairman Of The Board Of Directors
10/18/2017
Aelix Therapeutics announces the appointment of Dr. Thomas Hecht as chairman of its board of directors.
-
Former Eli Lilly Exec Emerges as the Front-Runner for Top HHS Job
10/18/2017
Alex Azar worked at the Department of Health and Human Services under President George W. Bush before joining drugmaker Eli Lilly.
-
Conceivex Release: Nation's Leading Fertility Therapy Company Appoints Life Sciences Veteran To Board of Directors
10/18/2017
Conceivex, maker of The Conception Kit at-home system, today named veteran life sciences industry executive Michael S. Rosen to its Board of Directors.
-
Dr. Jan Van De Winkel Joins Hookipa As Chairman Of Its Board Of Directors
10/18/2017
Hookipa Biotech, a company pioneering an innovative class of immunotherapies for oncology and infectious diseases, today announced the appointment of Dr. Jan van de Winkel as Chairman of its Board of Directors.
-
Phytecs Expands Scientific Advisory Board With Leading Experts In Mental Health, Inflammation, Metabolism And The Endocannabinoid System
10/18/2017
Phytecs, Inc., a biotechnology company exploring potential therapies that target the body's endocannabinoid system (ECS) to treat disease, today announced the addition of new members to the company's Scientific Advisory Board.
-
Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm
10/18/2017
The Court ordered Onxeo to pay SpeBio for costs incurred before termination the sum of 8.6 million euros with capitalized interest at the legal rate as of June 30, 2014.
-
Trillium Therapeutics' TTI-621 Program Featured at the EORTC CLTF Cutaneous Lymphoma Conference
10/18/2017
Trillium Therapeutics announced today that new preclinical data and a patient case study for its CD47-blocking agent, TTI-621 (SIRPa-IgG1 Fc), were presented at the EORTC CLTF meeting "Cutaneous Lymphomas - Insights and Therapeutic Progress", October 13-15, in London, England.
-
Celsion Provides Summary of Research and Development Day Held on October 12, 2017
10/18/2017
Leading ovarian cancer and immunotherapy experts discuss GEN-1 clinical programs in newly diagnosed Stage III/IV ovarian cancer patients.
-
Biogen Confirms Commitment to Tackle Multiple Sclerosis Through Comprehensive Approach
10/18/2017
Biogen confirms its comprehensive approach to tackle multiple sclerosis (MS) at the seventh Joint Meeting of the European Committee for Treatment and Research in MS and Americas Committee for Treatment and Research in MS (ECTRIMS-ACTRIMS; 25 - 28 October).
-
Scientific Update For Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production And Immune Cell Cryopreservation Recovery
10/18/2017
ProtoKinetix, Incorporated is pleased to provide a scientific update to its stockholders.
-
The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009
-
J&J Terminates Two Drugs From Pipeline
10/17/2017
Buried in its third-quarter financial announcement, J&J indicated it was dropping two of its pipeline drugs with little or no explanation. -
Novartis is closing its generic-drug manufacturing facility in Broomfield, Colo., which will cut 450 jobs over two years.
-
Takeda is jumping into the $40B market for NASH and other diseases of the liver with a $470M+ investment into HemoShear Therapeutics.